{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:46:08Z","timestamp":1760985968361,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["grant number C9545\/A17197","grant number C14303\/A17197"],"award-info":[{"award-number":["grant number C9545\/A17197","grant number C14303\/A17197"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Topographical variations of metabolite concentrations have been reported in the duodenum, jejunum and ileum of the small intestine, and in human intestinal tumours from those regions, but there are no published metabolite concentrations measurements correlated with linear position in the mouse small intestine or intestinal tumours. Since DNA methylation dynamics are influenced by metabolite concentrations, they too could show linear anatomical variation. We measured metabolites by HR-MAS <jats:sup>1<\/jats:sup>H NMR spectroscopy and DNA cytosine modifications by LC\/MS, in normal small intestines of C57BL\/6J wild-type mice, and in normal and tumour samples from <jats:italic>Apc<\/jats:italic><jats:sup><jats:italic>Min\/<\/jats:italic>+<\/jats:sup> mice. Wild-type mouse intestines showed approximately linear, negative concentration gradations from the pylorus (i.e. the junction with the stomach) of alanine, choline compounds, creatine, leucine and valine. <jats:italic>Apc<\/jats:italic><jats:sup><jats:italic>Min\/<\/jats:italic>+<\/jats:sup> mouse tumours showed negative choline and valine gradients, but a positive glycine gradient. 5-Hydroxymethylcytosine showed a positive gradient in the tumours. The linear gradients we found along the length of the mouse small intestine and in tumours contrast with previous reports of discrete concentration changes in the duodenum, jejunum and ileum. To our knowledge, this is also the first report of a systematic measurement of global levels of DNA cytosine modification in wild-type and <jats:italic>Apc<\/jats:italic><jats:sup><jats:italic>Min\/+<\/jats:italic><\/jats:sup> mouse small intestine.<\/jats:p>","DOI":"10.1038\/s41598-020-70579-w","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T06:06:55Z","timestamp":1597212415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ApcMin\/+ tumours and normal mouse small intestines show linear metabolite concentration and DNA cytosine hydroxymethylation gradients from pylorus to colon"],"prefix":"10.1038","volume":"10","author":[{"given":"Basetti","family":"Madhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Uribe-Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"70579_CR1","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1021\/pr0702565","volume":"6","author":"Y Wang","year":"2007","unstructured":"Wang, Y. et al. Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. J. Proteome Res.06, 3944\u20133951. https:\/\/doi.org\/10.1021\/pr0702565 (2007).","journal-title":"J. Proteome Res.0"},{"key":"70579_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1021\/pr050032r","volume":"4","author":"Y Wang","year":"2005","unstructured":"Wang, Y. et al. Biochemical characterization of rat intestine development using high-resolution magic-angle-spinning 1H NMR spectroscopy and multivariate data analysis. J. Proteome Res.4, 1324\u20131329. https:\/\/doi.org\/10.1021\/pr050032r (2005).","journal-title":"J. Proteome Res."},{"key":"70579_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/pr2011507","volume":"11","author":"Y Tian","year":"2012","unstructured":"Tian, Y., Zhang, L., Wang, Y. & Tang, H. Age-related topographical metabolic signatures for the rat gastrointestinal contents. J. Proteome Res.11, 1397\u20131411. https:\/\/doi.org\/10.1021\/pr2011507 (2012).","journal-title":"J. Proteome Res."},{"key":"70579_CR4","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1021\/pr900099x","volume":"8","author":"FP Martin","year":"2009","unstructured":"Martin, F. P. et al. Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. J. Proteome Res.8, 3464\u20133474. https:\/\/doi.org\/10.1021\/pr900099x (2009).","journal-title":"J. Proteome Res."},{"key":"70579_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1021\/pr8006232","volume":"8","author":"EC Chan","year":"2009","unstructured":"Chan, E. C. et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC\/MS). J. Proteome Res.8, 352\u2013361. https:\/\/doi.org\/10.1021\/pr8006232 (2009).","journal-title":"J. Proteome Res."},{"key":"70579_CR6","first-page":"1","volume":"1653","author":"RH Giles","year":"2003","unstructured":"Giles, R. H., van Es, J. H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta1653, 1\u201324 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"70579_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1021\/pr800793w","volume":"8","author":"A Backshall","year":"2009","unstructured":"Backshall, A. et al. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min\/+) mouse by (1)H MAS NMR spectroscopy. J. Proteome Res.8, 1423\u20131430. https:\/\/doi.org\/10.1021\/pr800793w (2009).","journal-title":"J. Proteome Res."},{"key":"70579_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41598-019-57214-z","volume":"10","author":"S Uribe-Lewis","year":"2020","unstructured":"Uribe-Lewis, S. et al. 5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation. Sci. Rep.10, 546. https:\/\/doi.org\/10.1038\/s41598-019-57214-z (2020).","journal-title":"Sci. Rep."},{"key":"70579_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrc3486","volume":"13","author":"W Timp","year":"2013","unstructured":"Timp, W. & Feinberg, A. P. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer13, 497\u2013510. https:\/\/doi.org\/10.1038\/nrc3486 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"70579_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/nchem.2064","volume":"6","author":"M Bachman","year":"2014","unstructured":"Bachman, M. et al. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem.6, 1049\u20131055. https:\/\/doi.org\/10.1038\/nchem.2064 (2014).","journal-title":"Nat. Chem."},{"key":"70579_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12272-015-0561-3","volume":"38","author":"V Chandra","year":"2015","unstructured":"Chandra, V. & Hong, K. M. Effects of deranged metabolism on epigenetic changes in cancer. Arch. Pharm. Res.38, 321\u2013337. https:\/\/doi.org\/10.1007\/s12272-015-0561-3 (2015).","journal-title":"Arch. Pharm. Res."},{"key":"70579_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1349-7006.2006.00348.x","volume":"98","author":"Y Yamada","year":"2007","unstructured":"Yamada, Y. & Mori, H. Multistep carcinogenesis of the colon in Apc(Min\/+) mouse. Cancer Sci.98, 6\u201310. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00348.x (2007).","journal-title":"Cancer Sci."},{"key":"70579_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jcb.20236","volume":"93","author":"D Leclerc","year":"2004","unstructured":"Leclerc, D., Deng, L., Trasler, J. & Rozen, R. ApcMin\/+ mouse model of colon cancer: Gene expression profiling in tumors. J. Cell Biochem.93, 1242\u20131254. https:\/\/doi.org\/10.1002\/jcb.20236 (2004).","journal-title":"J. Cell Biochem."},{"key":"70579_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1752-0509-8-72","volume":"8","author":"JE Dazard","year":"2014","unstructured":"Dazard, J. E., Sandlers, Y., Doerner, S. K., Berger, N. A. & Brunengraber, H. Metabolomics of ApcMin\/+ mice genetically susceptible to intestinal cancer. BMC Syst. Biol.8, 72. https:\/\/doi.org\/10.1186\/1752-0509-8-72 (2014).","journal-title":"BMC Syst. Biol."},{"key":"70579_CR15","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.stemcr.2017.10.013","volume":"9","author":"K Kozuka","year":"2017","unstructured":"Kozuka, K. et al. Development and characterization of a human and mouse intestinal epithelial cell monolayer platform. Stem Cell Rep.9, 1976\u20131990. https:\/\/doi.org\/10.1016\/j.stemcr.2017.10.013 (2017).","journal-title":"Stem Cell Rep."},{"key":"70579_CR16","first-page":"595","volume":"15","author":"NA Wright","year":"1982","unstructured":"Wright, N. A. & Irwin, M. The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: The steady state requirement. Cell Tissue Kinet,15, 595\u2013609 (1982).","journal-title":"Cell Tissue Kinet,"},{"key":"70579_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/gutjnl-2011-301601","volume":"62","author":"SJ Leedham","year":"2013","unstructured":"Leedham, S. J. et al. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut62, 83\u201393. https:\/\/doi.org\/10.1136\/gutjnl-2011-301601 (2013).","journal-title":"Gut"},{"key":"70579_CR18","volume-title":"The metabolism of tumours. Translated from the German edition by Frank Dickens","author":"O Warburg","year":"1930","unstructured":"Warburg, O. The metabolism of tumours. Translated from the German edition by Frank Dickens (Constable, London, 1930)."},{"key":"70579_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/abbi.2001.2471","volume":"393","author":"TF Fu","year":"2001","unstructured":"Fu, T. F., Rife, J. P. & Schirch, V. The role of serine hydroxymethyltransferase isozymes in one-carbon metabolism in MCF-7 cells as determined by (13)C NMR. Arch. Biochem. Biophys.393, 42\u201350. https:\/\/doi.org\/10.1006\/abbi.2001.2471 (2001).","journal-title":"Arch. Biochem. Biophys."},{"key":"70579_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab.23, 27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006 (2016).","journal-title":"Cell Metab."},{"key":"70579_CR21","doi-asserted-by":"publisher","first-page":"e0185980","DOI":"10.1371\/journal.pone.0185980","volume":"12","author":"B Madhu","year":"2017","unstructured":"Madhu, B., Jauhiainen, A., McGuire, S. & Griffiths, J. R. Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectra. PLoS\u00a0One12, e0185980. https:\/\/doi.org\/10.1371\/journal.pone.0185980 (2017).","journal-title":"PLoS\u00a0One"},{"key":"70579_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell.48, 612\u2013626. https:\/\/doi.org\/10.1016\/j.molcel.2012.08.033 (2012).","journal-title":"Mol. Cell."},{"key":"70579_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40170-017-0166-z","volume":"5","author":"LM Rodrigues","year":"2017","unstructured":"Rodrigues, L. M. et al. The action of beta-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: Evidence of a beta-hydroxybutyrate paradox. Cancer Metab.5, 4. https:\/\/doi.org\/10.1186\/s40170-017-0166-z (2017).","journal-title":"Cancer Metab."},{"key":"70579_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell19, 17\u201330. https:\/\/doi.org\/10.1016\/j.ccr.2010.12.014 (2011).","journal-title":"Cancer Cell"},{"key":"70579_CR25","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4161\/cc.25010","volume":"12","author":"MC Haffner","year":"2013","unstructured":"Haffner, M. C. et al. Tight correlation of 5-hydroxymethylcytosine and polycomb marks in health and disease. Cell Cycle12, 1835\u20131841. https:\/\/doi.org\/10.4161\/cc.25010 (2013).","journal-title":"Cell Cycle"},{"key":"70579_CR26","doi-asserted-by":"publisher","first-page":"17568","DOI":"10.1038\/srep17568","volume":"5","author":"CG Chapman","year":"2015","unstructured":"Chapman, C. G. et al. TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer. Sci. Rep.5, 17568. https:\/\/doi.org\/10.1038\/srep17568 (2015).","journal-title":"Sci. Rep."},{"key":"70579_CR27","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1101\/gad.288035.116","volume":"30","author":"R Kim","year":"2016","unstructured":"Kim, R., Sheaffer, K. L., Choi, I., Won, K. J. & Kaestner, K. H. Epigenetic regulation of intestinal stem cells by Tet1-mediated DNA hydroxymethylation. Genes Dev.30, 2433\u20132442. https:\/\/doi.org\/10.1101\/gad.288035.116 (2016).","journal-title":"Genes Dev."},{"key":"70579_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature468, 839\u2013843. https:\/\/doi.org\/10.1038\/nature09586 (2010).","journal-title":"Nature"},{"key":"70579_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18632\/oncotarget.316","volume":"2","author":"MC Haffner","year":"2011","unstructured":"Haffner, M. C. et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers. Oncotarget2, 627\u2013637. https:\/\/doi.org\/10.18632\/oncotarget.316 (2011).","journal-title":"Oncotarget"},{"key":"70579_CR30","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","volume":"71","author":"SG Jin","year":"2011","unstructured":"Jin, S. G. et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res71, 7360\u20137365. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2023 (2011).","journal-title":"Cancer Res"},{"key":"70579_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ijc.27429","volume":"131","author":"TF Kraus","year":"2012","unstructured":"Kraus, T. F. et al. Low values of 5-hydroxymethylcytosine (5hmC), the \u201csixth base,\u201d are associated with anaplasia in human brain tumors. Int. J. Cancer131, 1577\u20131590. https:\/\/doi.org\/10.1002\/ijc.27429 (2012).","journal-title":"Int. J. Cancer"},{"key":"70579_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature11282","volume":"488","author":"S Seshagiri","year":"2012","unstructured":"Seshagiri, S. et al. Recurrent R-spondin fusions in colon cancer. Nature488, 660\u2013664. https:\/\/doi.org\/10.1038\/nature11282 (2012).","journal-title":"Nature"},{"key":"70579_CR33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian, C. G. et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell150, 1135\u20131146. https:\/\/doi.org\/10.1016\/j.cell.2012.07.033 (2012).","journal-title":"Cell"},{"key":"70579_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/onc.2012.67","volume":"32","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene32, 663\u2013669. https:\/\/doi.org\/10.1038\/onc.2012.67 (2013).","journal-title":"Oncogene"},{"key":"70579_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062828","author":"CG Liu","year":"2013","unstructured":"Liu, C. G. et al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS\u00a0One\nhttps:\/\/doi.org\/10.1371\/journal.pone.0062828 (2013).","journal-title":"PLoS\u00a0One"},{"key":"70579_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4155\/Bio.13.28","volume":"5","author":"LT Zhang","year":"2013","unstructured":"Zhang, L. T. et al. Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line. Bioanalysis5, 839\u2013845. https:\/\/doi.org\/10.4155\/Bio.13.28 (2013).","journal-title":"Bioanalysis"},{"key":"70579_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-015-0605-5","volume":"16","author":"S Uribe-Lewis","year":"2015","unstructured":"Uribe-Lewis, S. et al. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer. Genome Biol.16, 69. https:\/\/doi.org\/10.1186\/s13059-015-0605-5 (2015).","journal-title":"Genome Biol."},{"key":"70579_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13578-015-0013-2","volume":"5","author":"Y Guo","year":"2015","unstructured":"Guo, Y. et al. Association of aberrant DNA methylation in Apc(min\/+) mice with the epithelial-mesenchymal transition and Wnt\/beta-catenin pathways: Genome-wide analysis using MeDIP-seq. Cell Biosci.5, 24. https:\/\/doi.org\/10.1186\/s13578-015-0013-2 (2015).","journal-title":"Cell Biosci."},{"key":"70579_CR39","volume-title":"The Biology of Epithelial Cell Populations\/Nicholas Wright and Malcolm Alison","author":"NA Wright","year":"1984","unstructured":"Wright, N. A. The Biology of Epithelial Cell Populations\/Nicholas Wright and Malcolm Alison (Oxford University Press, Oxford, 1984)."},{"key":"70579_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11306-016-1055-0","volume":"12","author":"B Madhu","year":"2016","unstructured":"Madhu, B., Shaw, G. L., Warren, A. Y., Neal, D. E. & Griffiths, J. R. Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy. Metabolomics12, 120. https:\/\/doi.org\/10.1007\/s11306-016-1055-0 (2016).","journal-title":"Metabolomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70579-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T10:27:59Z","timestamp":1670322479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70579-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70579-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"5 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13616"}}